[go: up one dir, main page]

GB202105047D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB202105047D0
GB202105047D0 GBGB2105047.1A GB202105047A GB202105047D0 GB 202105047 D0 GB202105047 D0 GB 202105047D0 GB 202105047 A GB202105047 A GB 202105047A GB 202105047 D0 GB202105047 D0 GB 202105047D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2105047.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beckley Psytech Ltd
Original Assignee
Beckley Psytech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckley Psytech Ltd filed Critical Beckley Psytech Ltd
Priority to GBGB2105047.1A priority Critical patent/GB202105047D0/en
Publication of GB202105047D0 publication Critical patent/GB202105047D0/en
Priority to BR112022025306A priority patent/BR112022025306A2/en
Priority to EP24213283.5A priority patent/EP4483957A3/en
Priority to CA3187020A priority patent/CA3187020A1/en
Priority to CN202411802400.4A priority patent/CN119613319A/en
Priority to EP21735380.4A priority patent/EP3941904A1/en
Priority to EP24208163.6A priority patent/EP4595962A3/en
Priority to JP2022576811A priority patent/JP2023530292A/en
Priority to FIEP23157604.2T priority patent/FI4279070T3/en
Priority to CN202180055398.7A priority patent/CN116056762B/en
Priority to KR1020237001336A priority patent/KR20230024378A/en
Priority to EP21735379.6A priority patent/EP3941583B9/en
Priority to PCT/GB2021/051475 priority patent/WO2021250434A1/en
Priority to EP23157604.2A priority patent/EP4279070B1/en
Priority to AU2021289147A priority patent/AU2021289147A1/en
Priority to PCT/GB2021/051476 priority patent/WO2021250435A1/en
Priority to ES23157604T priority patent/ES3007386T3/en
Priority to IL298871A priority patent/IL298871A/en
Priority to DK23157604.2T priority patent/DK4279070T3/en
Priority to US17/660,873 priority patent/US11518742B2/en
Priority to US17/660,981 priority patent/US11518743B2/en
Priority to US17/817,548 priority patent/US11603353B2/en
Priority to US17/935,256 priority patent/US11680044B2/en
Priority to US18/162,976 priority patent/US20230348381A1/en
Priority to US18/310,822 priority patent/US20230382858A1/en
Ceased legal-status Critical Current

Links

GBGB2105047.1A 2020-06-12 2021-04-08 Pharmaceutical composition Ceased GB202105047D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GBGB2105047.1A GB202105047D0 (en) 2021-04-08 2021-04-08 Pharmaceutical composition
DK23157604.2T DK4279070T3 (en) 2020-06-12 2021-06-14 COMPOSITION COMPRISING A BENZOATE SALT OF 5-METHOXY-N,N-DIMETHYLTRYPTAMINE
PCT/GB2021/051475 WO2021250434A1 (en) 2020-06-12 2021-06-14 Composition comprising a benzoate salt of 5-methoxy-n,n-dimethyltryptamine
AU2021289147A AU2021289147A1 (en) 2020-06-12 2021-06-14 Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamine
CA3187020A CA3187020A1 (en) 2020-06-12 2021-06-14 Composition comprising a benzoate salt of 5-methoxy-n,n-dimethyltryptamine
CN202411802400.4A CN119613319A (en) 2020-06-12 2021-06-14 Compositions containing benzoate salt of 5-methoxy-N,N-dimethyltryptamine
EP21735380.4A EP3941904A1 (en) 2020-06-12 2021-06-14 Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamine
EP24208163.6A EP4595962A3 (en) 2020-06-12 2021-06-14 Pharmaceutical composition
JP2022576811A JP2023530292A (en) 2020-06-12 2021-06-14 Compositions containing the benzoate salt of 5-methoxy-N,N-dimethyltryptamine
FIEP23157604.2T FI4279070T3 (en) 2020-06-12 2021-06-14 Composition comprising a benzoate salt of 5-methoxy-n,n-dimethyltryptamine
CN202180055398.7A CN116056762B (en) 2020-06-12 2021-06-14 Compositions containing benzoate salt of 5-methoxy-N,N-dimethyltryptamine
KR1020237001336A KR20230024378A (en) 2020-06-12 2021-06-14 A composition comprising the benzoate salt of 5-methoxy-N,N-dimethyltryptamine
EP21735379.6A EP3941583B9 (en) 2020-06-12 2021-06-14 Composition comprising a benzoate salt of 5-methoxy-n,n-dimethyltryptamine
BR112022025306A BR112022025306A2 (en) 2020-06-12 2021-06-14 COMPOSITION COMPRISING A BENZOATE SALT OF 5-METHOXIN, N-DIMETHYLTRIPTAMINE
EP23157604.2A EP4279070B1 (en) 2020-06-12 2021-06-14 Composition comprising a benzoate salt of 5-methoxy-n,n-dimethyltryptamine
EP24213283.5A EP4483957A3 (en) 2020-06-12 2021-06-14 Pharmaceutical composition
PCT/GB2021/051476 WO2021250435A1 (en) 2020-06-12 2021-06-14 Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamine
ES23157604T ES3007386T3 (en) 2020-06-12 2021-06-14 Composition comprising a benzoate salt of 5-methoxy-n,n-dimethyltryptamine
IL298871A IL298871A (en) 2020-06-12 2021-06-14 The composition consisting of the benzoate salt of 5-methoxy-N,N-dimethyltryptamine
US17/660,981 US11518743B2 (en) 2020-06-12 2022-04-27 Pharmaceutical composition comprising 5-methoxy-N,N-dimethyltryptamine
US17/660,873 US11518742B2 (en) 2020-06-12 2022-04-27 Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamine
US17/817,548 US11603353B2 (en) 2020-06-12 2022-08-04 Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamine
US17/935,256 US11680044B2 (en) 2020-06-12 2022-09-26 Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamine
US18/162,976 US20230348381A1 (en) 2020-06-12 2023-02-01 Composition comprising a benzoate salt of 5-methoxy-n,n-dimethyltryptamine
US18/310,822 US20230382858A1 (en) 2020-06-12 2023-05-02 Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2105047.1A GB202105047D0 (en) 2021-04-08 2021-04-08 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB202105047D0 true GB202105047D0 (en) 2021-05-26

Family

ID=75949418

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2105047.1A Ceased GB202105047D0 (en) 2020-06-12 2021-04-08 Pharmaceutical composition

Country Status (1)

Country Link
GB (1) GB202105047D0 (en)

Similar Documents

Publication Publication Date Title
GB202019241D0 (en) Pharmaceutical composition
IL304290A (en) Pharmaceutical composition
GB201911517D0 (en) Pharmaceutical composition
IL300090A (en) Pharmaceutical compositions comprising venglustat
PL3908321T3 (en) Pharmaceutical composition
IL285728A (en) Pharmaceutical composition
GB202104224D0 (en) Pharmaceutical composition
GB202018068D0 (en) Pharmaceutical composition
GB202019335D0 (en) Pharmaceutical compositions
GB202208464D0 (en) Pharmaceutical composition
GB202109271D0 (en) Pharmaceutical composition
GB202108387D0 (en) Pharmaceutical composition
GB202107518D0 (en) Pharmaceutical composition
GB202105858D0 (en) Pharmaceutical composition
GB202105462D0 (en) Pharmaceutical composition
GB202105047D0 (en) Pharmaceutical composition
GB202105049D0 (en) Pharmaceutical composition
GB202102095D0 (en) Pharmaceutical composition
GB202102100D0 (en) Pharmaceutical composition
GB202101638D0 (en) Pharmaceutical composition
GB202101634D0 (en) Pharmaceutical composition
GB202101640D0 (en) Pharmaceutical composition
GB202101123D0 (en) Pharmaceutical composition
GB202100711D0 (en) Pharmaceutical composition
GB202020504D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)